The predisposition to thrombogenesis is increased in essential hypertension, and hypertensive patients are prone to develop more vulnerable atherosclerotic plaques. To evaluate the possible influence of family history of hypertension on some indicators of early atherosclerosis, we studied eighty-five healthy normotensive individuals with (FH þ ) or without (FHÀ) family history of essential hypertension by measuring metabolic profile and concentrations of P-selectin, interleukin 6 and matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of metalloproteinase (TIMP)-1. In a subset of individuals, MMP-9 activity was assessed in monocytes by zymography, and TIMP-1 expression by western blot. As compared with FHÀ individuals, FH þ individuals had significantly higher P-selectin but similar interleukin-6 levels. Although no difference was observed in MMP-2 levels between the two groups, MMP-9 and TIMP-1 were higher in FH þ individuals, who also had higher intracellular MMP-9 levels and TIMP-1 protein expression. P-selectin (r ¼ À0.32; Po0.01), MMP-9 (r ¼ À0.37; Po0.001) and TIMP-1 (r ¼ À0.23; Po0.05) levels were inversely related to high density lipoprotein (HDL) cholesterol. P-selectin was also directly related to serum triglycerides (r ¼ 0.30; Po0.01). We conclude that a positive family history of hypertension is associated with an initial increase in markers of inflammation and plaque instability in otherwise healthy young normotensive individuals, likely conveying a predisposition to develop early atherothrombosis.
Introduction
Although hypertension is a well-recognized risk factor for the development of atherosclerotic cardiovascular disease, 1,2 the blood pressure level itself is only one of the several components of hypertensive disease. Thus, familial clustering of hypertension in young normotensive individuals has been shown to be associated with an increased incidence of high serum cholesterol levels, left ventricular dysfunction, reduced arterial compliance and insulin resistance. 3, 4 In hypertensive individuals, predisposition to thrombosis manifests itself as changes in platelet aggregation and endothelial function, activation of coagulation and inhibition of fibrinolysis. Moreover, the composition of the atherosclerotic plaque rather than the degree of stenosis seems to determine the risk of plaque rupture and subsequent thrombosis. Histological features of vulnerable plaques include a large lipid core, a thin fibrous cap, intraplaque haemorrhage and an increased number of inflammatory cells, mostly monocytes-macrophages. 5, 6 The matrix metalloproteinase (MMP) proteolytic system and the natural tissue endogenous inhibitors (tissue inhibitor of metalloproteinase (TIMP)) are involved in the regulation of extracellular matrix metabolism, thus contributing to the vulnerability of the atherosclerotic lesion.
Whether plasma levels and activities of MMP-2, MMP-9 and TIMP-1 are altered in hypertensive patients is still under debate, as both increases and decreases in these factors have been reported. 7, 8 Raised MMP-9 levels seem to be associated with a higher Framingham cardiovascular disease risk score, 9 and increased TIMP-1 has been reported to be an independent predictor of myocardial infarction and cardiac mortality. 10 In animal models of chronic heart failure, selective matrix MMP inhibition attenuates the progression of left ventricular dysfunction and remodelling.
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Among other markers of early atherosclerosis, circulating P-selectin and interleukin-6 (IL-6) levels seem to be particularly relevant. P-selectin is a marker of platelet activation that has been linked with an adverse cardiovascular prognosis. 12 Raised soluble P-selectin levels have been reported in diabetes, smoking, hypertension and hypercholesterolaemia.
13,14 IL-6 is reputed to play a key role in the development of coronary disease through effects on metabolism, endothelial function and coagulation. IL-6 stimulates lipolysis and fat oxidation, 15 and enhances platelet aggregability and fibrinogen concentrations leading to a pro-coagulant state. 16 Although certain markers of inflammation and prothrombotic state are elevated in persons at risk of future cardiovascular events like hypertensive individuals, 13, 17 data on the relation between inflammatory markers of vascular risk and family history of hypertension, defined as presence of hypertension in first degree relatives, are limited. Therefore, this study was undertaken to gain information on the possible influence of familial predisposition to hypertension on some indicators of high atherothrombotic risk in otherwise healthy individuals.
Patients and methods
Eighty-five young healthy volunteers were consecutively enroled among postdoctoral fellows. Inclusion criteria were age o30 years, absence of any concomitant acute or chronic illness, negative family history of diabetes, fasting plasma glucose below 110 mg per 100 ml, normal blood pressure values according to the JNC 7 criteria, 18 body mass index (BMI) o25 kg m -2 and no ongoing pharmacological therapies. The study protocol was approved by the Ethics Committee of the University of Pisa. All participants gave their written informed consent. Three days before the study, participants received a form to report clinical information on their parents (age, BMI, waist circumference and history of hypertension). On the day of the study, participants and parents attended our clinical research center after an overnight (10-12 h) fast to undergo a complete clinical examination. Height and weight were recorded, and waist circumference was obtained as the average of two measurements while the patient was standing (one taken after inspiration and the other after expiration), at the midpoint between the lowest rib and the iliac crest. Blood pressure was measured in the sitting position with a mercury sphygmomanometer after a 10-min rest. Blood samples were collected from the antecubital vein; samples were separated into aliquots for the preparation of serum and plasma. Serum was analyzed for glucose, cholesterol, triglycerides, high density lipoprotein (HDL) cholesterol, creatinine and uric acid. Plasma was kept at À70 1C for later analysis of MMPs and cytokines.
Analytical techniques
Fasting plasma glucose was measured by the hexokinase method. The levels of total cholesterol and triglycerides were determined by an enzymatic colorimetric assay, with the use of an RA-1000 analyzer (Technicon Instruments Ltd, Terrytown, NY, USA). HDL cholesterol was measured enzymatically from the supernatant after precipitation of other lipoproteins with dextran sulphate magnesium. Levels of low density lipoprotein cholesterol were calculated by the Friedewald formula. The uricase/PAP method (an enzymatic colour test) and a modification of the Jaffé method were used to determine uric acid and creatinine, respectively. Soluble P-selectin was measured in citrated plasma by enzyme-linked immunosorbent assay, using commercial reagents (R&D Systems, Abingdon, UK). The lower detection limit was 0.5 ng ml -1 . The intrassay coefficient of variation was o5%, and the inter-assay variation coefficient was o10%. IL-6 was measured by an enzyme-linked immunosorbent assay using a biotin-conjugated monoclonal anti-IL-6 antibody (Bioscience, San Diego, CA, USA). The mean lower detection limit was 0.039 pg ml -1 , and the interassay coefficient of variation was 5.2%. Serum MMP-2, MMP-9 and TIMP-1 levels were assessed by commercially available immunoadsorbent assay kits (R&D Systems). All assays were run in duplicate. The lower detection limits were: 0.78 ng ml -1 for MMP-2, 0.156 ng ml -1 for MMP-9 and 0.08 ng ml -1 for TIMP-1. The intraassay coefficient of variation was 5.5-7.0% for MMP-2, 5.5-6.5% for MMP-9 and 2.8-3.5% for TIMP-1.
Studies on monocytes
Monocytes were isolated from the peripheral blood of eight randomly chosen participants with, and eight participants without, family history of hypertension by Lymphoprep tubes (Axis Shield, Oslo, Norway) according to the manufacturer's instructions. Cellular extracts were obtained by harvesting cells in the presence of radioimmunoprecipitation assay buffer (PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS), 10 mg ml -1 phenylmethylsulfonyl fluoride, 30 mg ml -1 aprotinin and 5 mg ml -1 leupeptin). Protein concentrations were determined by Bradford reagent. For zymography, equal amounts of non-reduced protein (30 mg) were loaded onto an 8% SDS-polyacrylamide gel electrophoresis containing 1% gelatin. After electrophoretic separation, gels were renatured by incubation in 2.5% Triton X-100 for 30 min, and gelatinase activity was shown by overnight incubation in a developing buffer (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 5 mM CaCl 2 and 0.02% Brij35) and staining with 0.5% Coomassie blue G-250. The clear bands against the blue background indicated the presence of the latent form of MMP-9 (92 kDa) analyzed as total activity. The integrated optical density of the individual bands was determined using the bio-imaging system (NIH image software 1.62) and normalized against the value of a standard sample that was run on every gel.
For western blot analysis, proteins were extracted in radioimmunoprecipitation assay-buffer containing freshly dissolved protease inhibitors and blocked with 5% non-fat dry milk in Tris-buffered saline Tween 20 at 4 1C. Denatured protein (50 mg total) was subjected to SDS-polyacrylamide gel electrophoresis on a 15% polyacrylamide gel, and separated proteins were electrically transferred onto polyvinylidene difluoride (PVDF) membranes (BioRad, Hercules, CA, USA). After blocking the nonspecific background, PVDF membranes were incubated with the antibody for anti-rabbit polyclonal TIMP-1 (AB8116; 1:1000) for 1 h at room temperature. After washing the membrane with Tween 20 buffer, membranes were incubated with goat antirabbit horseradish peroxidase (1:1000) for 1 h at room temperature. To ensure inter-gel reproducibility, running times, staining and destaining procedures of the electrophoresis were standardized. Signals were immunodetected by chemiluminescence (Amersham Pharmacia Biotech, Piscataway, NJ, USA), and the intensities of the band were analyzed densitometrically using the NIH program 1.62.
Statistical analysis
Values are expressed as mean ± s.d. or median and interquartile range. Group comparisons were carried out using the nonparametric Mann-Whitney U-test or the unpaired t-test, for variables with non-normal or normal distribution, respectively; proportions were compared by the w 2 -test. Power calculation was as follows: for a two-tailed a of 0.05 and a onetailed b of 1.282, our sample size allowed the detection of a minimal difference of 17 ng ml -1 for TIMP-1 and 11 ng ml -1 for P-selectin. Relationships between variables were assessed using multiple linear regression analysis and Spearman's correlation analysis. The statistical significance was determined on a probability level of p0.05. Data were analyzed by StatView for Windows.
Results
The individuals with family history of essential hypertension (FH þ ) and those without (FHÀ) were well matched on the main anthropometric and clinical characteristics ( Table 1) . Prevalence of hypertension was higher in fathers than in mothers of FH þ individuals. Adiposity (as the BMI) and body fat distribution (as the waist circumference) were similar in the parents of FH þ vs FHÀ individuals, although maternal waist girth was significantly higher among FH þ than FHÀ individuals (Table 2) .
Plasma levels of P-selectin-but not IL-6-were higher in FH þ than FHÀ individuals. Likewise, circulating concentrations of MMP-9 and TIMP-1 were higher in FH þ than FHÀ individuals (Table 3) . MMP-2 levels showed a similar trend but did not reach a statistical significance.
Owing to the different MMP pattern in the two groups, we determined the pro-MMP-9 levels in monocytes of eight randomly selected participants with double parental history of hypertension and in eight FHÀ participants. As shown in Figure 1 , intracellular MMP-9 levels and TIMP-1 protein expression were both higher in FH þ than FHÀ participants. P-selectin (r ¼ À0.32; Po0.01), MMP-9 (r ¼ À0.37; Po0.001) and TIMP-1 (r ¼ À0.23; Po0.05) levels were each inversely related to serum HDL cholesterol levels. P-selectin was also directly related to serum triglycerides (r ¼ 0.30; Po0.01); a similar trend was also obtained with TIMP-1 (r ¼ 0.21; 
Discussion
This study shows for the first time that young healthy individuals with family history of essential hypertension are characterized by higher circulating P-selectin levels and an increased activation of the MMP-TIMP system, in comparison with carefully matched individuals without family history of hypertension.
Family history of hypercholesterolaemia, hypertension and diabetes each has been linked with an enhanced risk of developing atherosclerosis. P-selectin is also expressed in the endothelium overlying atherosclerotic plaques, 19 and increased P-selectin levels have been shown to be associated with increased incidence of coronary artery disease. 20 Thus, high P-selectin levels might promote an early endothelial damage and accelerate the development of atherosclerotic plaques in individuals with family history of hypertension. Alternatively, raised P-selectin levels could reflect enhanced platelet activation. Changes in MMP or TIMP activity may contribute to atherosclerotic plaque remodelling; in particular, MMP-2 and MMP-9 are involved in the degradation of the fibrous cap leading to plaque erosion. Circulating levels of both MMP-9 and TIMP-1 have been reported to be increased in patients with hypertension, and to decrease with antihypertensive treatment. 9 Thus, the higher MMP-9 of our FH þ individuals might be seen as a biochemical marker of susceptibility to increased plaque instability. Moreover, an association between MMP-9 levels and aortic stiffness has been reported, not only in hypertensive individuals, but also in younger, apparently healthy individuals, 21 in which two common variants of the MMP-9 gene have been associated with arterial stiffness, likely attributable to enhanced degradation of the wall matrix. 22 The clinical relevance of our observation is reinforced by the present finding of enhanced intracellular MMP-9 Tissue inhibitor of metalloproteinase-1 is an important regulator of cell growth, and is thought to increase tissue concentrations of type I collagen by preventing its breakdown by MMPs. TIMP-1 levels are typically elevated in hypertension and correlate with left ventricular mass and indices of diastolic dysfunction. 23 Our finding of increased TIMP-1 levels in FH þ individuals-and the increased TIMP-1 protein expression in monocytes of individuals with double family history of hypertension-can be interpreted to mark an activation of the MMP-TIMP system, possibly triggered by the higher MMP-9 levels. Whether this pattern implies proneness to fibrosis or changes in matrix composition conducive to plaque instability cannot be deduced from the available data. Moreover, the degree of pattern activation may not necessarily be similar in all vascular districts, given that a differential gene expression profiling of TIMP-1 in atherosclerotic plaques and coronary plaques has been recently described. 24 A difference in MMP levels between patients with stable angina and with acute symptoms of coronary heart disease has been recently shown, 25 suggesting a graded effect of this marker on the disease. The TIMP-1 and MMP-9 levels measured in our normotensive cohort are lower in absolute value than those described in hypertensive patients, compatible with a progressive involvement of the system in the natural history of the hypertensive. In keeping with this interpretation is also the finding that our young normotensive cohort-with or without familial hypertension-lacked evidence of subclinical inflammation.
MMP-
Even in the presence of a trend, the MMP-2 levels did not reach a significant difference between the two groups of participants; this dichotomy between the two gelatinases has been recently described in other conditions, like gestational hypertension and ischaemic stroke with haemorrhagic complications. 26, 27 With regard to serum IL-6 levels, we did not detect any difference between FH þ and FHÀ individuals. IL-6 is released largely by adipocytes, and plays a role in the modulation of adiposity and body fat distribution. [28] [29] [30] Recent large-scale studies and meta-analyses indicate that IL-6 À174 G/C polymorphism is not associated with risk of premature CAD or type II diabetes. 31, 32 These observations are in line with our result of relatively low IL-6 levels in our cohort of non-obese individuals.
Even though both paternal and maternal BMI tended to be higher in hypertensive than normotensive parents, the only significant difference in the parental phenotype between FHÀ and FH þ individuals was a higher maternal waist circumference in FH þ (even in the presence of similar waist values in FHÀ and FH þ probands). The significance of this finding is uncertain; it could represent a potentially additive risk factor, as described for the insulin resistance syndrome. 33 The inverse correlation between HDL cholesterol and P-selectin, MMP-9 and TIMP-1 levels is of interest. HDL cholesterol inhibits the cytokineinduced expression of endothelial cell adhesion molecules. 34, 35 Accordingly, the higher P-selectin levels in FH þ individuals may stand for incipient endothelial dysfunction, an observation that has been made earlier in the offspring of hypertensive patients. 36 Analogously, the inverse relation of HDL to MMP-9, already observed in untreated hypertensive patients, 9 might suggest a role for this molecule as an early marker of increased CV risk for this molecule. The direct correlation between P-selectin and serum triglycerides, which contribute independent risk to atherogenesis, 37 has the same potential implication. The correlation between TIMP-1 and BMI, already observed in obese adults and adolescents, 38 confirms the role of this cytokine in adipose tissue accumulation. 39 This study has considerable limitations. First, the size of the cohort is relatively small, and the crosssectional nature of the findings precludes the indication of cause-and-effect relationships. Second, the correlations observed in the results were weak, if statistically significant. Third, information on the presence of the MMP-TIMP system at the level of arterial or cardiac tissues would provide strong support for the concept of a link between cardiovascular risk and MMPs in these individuals. Fourth, we could not relate our findings to evidence of target organ damage.
In conclusion, a positive family history of hypertension is associated with an initial increase in markers of inflammation and plaque instability in otherwise healthy young normotensive individuals, likely conveying a further predisposition to a premature atherothrombotic disease in these asymptomatic individuals; follow up of these individuals is needed to confirm this hypothesis, together with genetic studies addressing the possible utilization of these markers for future preventive strategies.
